New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 23, 2014
08:57 EDTAMAGAMAG Pharmaceuticals price target lowered to $30 from $43 at Summer Street
Summer Street lowered its price target for AMAG Pharmaceuticals to $30 following the company's complete response letter for a broader indication of Feraheme. The firm keeps a Buy rating on the stock.
News For AMAG From The Last 14 Days
Check below for free stories on AMAG the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 14, 2014
10:05 EDTAMAGOn The Fly: Analyst Initiation Summary
Subscribe for More Information
05:35 EDTAMAGAMAG Pharmaceuticals initiated with a Market Perform at FBR Capital
Subscribe for More Information
August 12, 2014
08:21 EDTAMAGAMAG Pharmaceuticals appoints Robert Blood as Chief Compliance Officer
Subscribe for More Information
August 7, 2014
14:16 EDTAMAGJames Flynn reports 5.99% passive stake in AMAG Pharmaceuticals
August 6, 2014
06:22 EDTAMAGJefferies to hold a summit
Boston Healthcare Summit to be held in Boston on August 6.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use